Which phase of clinical development most commonly identifies common adverse drug reactions?
Show answer and explanation
Correct answer: Phase III trials
Phase III trials involve large patient populations and are designed to assess both efficacy and safety. Common adverse reactions are often detected at this stage before marketing approval.
Keep practicing
More Pharmacovigilance questions
- The Naranjo algorithm is used to:
- Which of the following is considered a serious adverse event?
- Pharmacovigilance activities are most crucial after marketing because:
- Which document must manufacturers regularly submit to regulatory authorities summarizing accumulated post-marketing safety data on an appro…
- Which pharmacovigilance method is widely acknowledged to capture only a fraction of all drug-related adverse events that actually occur?
- Which pharmacovigilance term encompasses any undesirable clinical occurrence following drug exposure, regardless of whether the drug caused…